US$ 20.40
risks of glp-1 drugs GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment GI Adverse Effects of Glucagon-Like
Description
Voerman E, Santos S, Inskip H, Amiano P, LifeCycle Project-Maternal O, Childhood Outcomes Study G, et al

2018 ACC Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease
44S168S179

Its important to remain patient and consistent, as the full benefits of semaglutide are typically realized over a longer period

doi: 10.1093/ckj/sfae296
Interesting to see how this behaves as a commercial product
